nocodazole has been researched along with Anaplastic Astrocytoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hawes, JJ; Nerva, JD; Reilly, KM | 1 |
| Chen, J; Donovan, S; Hong, FD; Nisen, PD; Schneider, N | 1 |
2 other study(ies) available for nocodazole and Anaplastic Astrocytoma
| Article | Year |
|---|---|
Novel dual-reporter preclinical screen for antiastrocytoma agents identifies cytostatic and cytotoxic compounds.
Topics: Animals; Antineoplastic Agents; Astrocytoma; Camptothecin; Cytostatic Agents; Cytotoxins; Drug Evaluation, Preclinical; Genes, Reporter; Humans; Nocodazole; Reproducibility of Results | 2008 |
Taxol, vincristine or nocodazole induces lethality in G1-checkpoint-defective human astrocytoma U373MG cells by triggering hyperploid progression.
Topics: Astrocytoma; Cell Cycle; Cell Cycle Proteins; Cell Death; Cell Division; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Enzyme Inhibitors; Fibroblasts; Flow Cytometry; Humans; Hydroxyurea; Karyotyping; Microtubule-Associated Proteins; Nocodazole; Paclitaxel; Phosphorylation; Polyploidy; Retinoblastoma Protein; Thymidine; Tumor Cells, Cultured; Tumor Suppressor Proteins; Vincristine | 1999 |